MONTRÉAL, Feb. 11, 2015 /CNW Telbec/ - Shire Pharma Canada ULC ("Shire Canada") announces today the launch of the 3rd edition of its scholarship program for adults with Attention Deficit Hyperactivity Disorder (ADHD) pursuing a post-secondary education. Individuals interested and otherwise eligible to participate in the Shire Canada ADHD Scholarship Program have until April 20, 2015 to submit their applications. All relevant details, including the eligibility criteria, rules and how to apply can be found on the Program website at www.ShireADHDScholarship.com.
"We have been happily surprised by the number of applications submitted to the Shire Canada ADHD Scholarship Program over the last two years," said Eric Tse, General Manager for Shire in Canada. "We are pleased to make the Program available for a third year in a row and to continue to support Canadian adults with ADHD in reaching their full academic potential."
All applications received as part of the Shire Canada ADHD Scholarship Program are evaluated and rated by an independent jury panel of Canadian ADHD experts. A total of five scholarships will be awarded in 2015 (allowing for exceptions), and the names of the winners will be announced towards the end of the summer.
About the Shire Canada ADHD Scholarship Program
The Shire Canada ADHD Scholarship Program was created to help adults with ADHD reach their full academic potential. Each of the five (5) scholarships consists of: 1) financial support of CAN$1,500 and 2) ADHD coaching services from the Edge Foundation, a non-profit organization that offers coaching services designed specifically for students with ADHD (approximate value of CAN$4,400). To participate, eligible adults must submit an application online, via the Program website. The winners are selected following the evaluation of applications by an independent panel of judges composed of Canadian ADHD experts. Complete details are available on the Program website at: www.ShireADHDScholarship.com.
About Shire
Shire enables people with life-altering conditions to lead better lives.
Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs.
We provide treatments in Neuroscience, Rare Diseases, Gastrointestinal, and Internal Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas, such as Ophthalmics.
About Shire Pharma Canada ULC
Shire Pharma Canada ULC is a subsidiary of Shire with headquarters located in Montréal (Saint‑Laurent), Québec. For more information, please visit www.shirecanada.com.
SOURCE Shire Canada Inc.
Brigitte Viel, 514-787-5114, [email protected]
Share this article